Long-term effects of photobiomodulation therapy on blood pressure in obese rats induced by a high-fat diet.
Lasers Med Sci
; 39(1): 20, 2024 Jan 02.
Article
em En
| MEDLINE
| ID: mdl-38165554
ABSTRACT
The main cardiovascular disease risk associated with obesity is hypertension. The therapeutic use of photobiomodulation therapy (PBM) is suggested for the treatment of wound healing, osteoarthritis, and arterial diseases. However, few studies have measured how red laser (at 660 nm) acts over hypertension, and any of those studies used experimental obesity model. The aim of the study was an attempt to evaluate the long-term effect of PBM on systolic blood pressure in an animal model of obesity, induced by a high-fat diet (HFD). Our results indicate that PBM carried out 3 days a week was able to prevent the increase in blood pressure (133.75 ± 4.82 mmHg, n = 8) induced by a high-fat diet (150.00 ± 4.57 mmHg, n = 8; p < 0.05), restore nitric oxide levels (control 31.7 ± 5.5 µM, n = 8; HFD + PBM 29.9 ± 3.7 µM, n = 8 > HFD 22.2 ± 2.9 µM, n = 8, p < 0.05), decrease lipoperoxidation (control 1.65 ± 0.25 nM, n = 8; HFD + PBM 2.05 ± 0.55 nM, n = 8 < HFD 3.20 ± 0.47 nM, n = 8; p < 0.05), and improve endothelial function (pD2 control 7.39 ± 0.08, n = 8 > pD2 HFD + PBM 7.15 ± 0.07, n = 8 > HFD 6.94 ± 0.07, n = 8; p < 0.05). Our results indicate that PBM prevents the elevation of blood pressure in an obese animal model by a mechanism that involves improvement of endothelial function through an antioxidant effect.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Métodos Terapêuticos e Terapias MTCI:
Terapias_energeticas
Assunto principal:
Terapia com Luz de Baixa Intensidade
/
Hipertensão
Idioma:
En
Revista:
Lasers Med Sci
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Brasil